The Latest Breaking News from FDA

The former president is reviving campaign promises to undo Obamacare, an idea that fizzled during his first time in office. Based on his record, here's what else he might do in health policy.

The points about marijuana's risks and benefits that the department now concedes were clear long before last August.

Sixty years ago, the U.S. surgeon general released a report that settled a longstanding public debate about the dangers of cigarettes and led to huge changes in smoking in America

Modern medical devices are lifesavers. But they’re vulnerable to hackers and compromise our privacy.

With no shortage of major releases on the docket, 2024 is likely to be an exciting year in the world of smartwatches.

Find out about a review by the FDA supporting the reclassification of marijuana as a Schedule 3 substance due to its lower abuse potential and accepted med...

The pharmaceutical sector is anticipated to prosper due to the strong demand for drugs and therapies and the adoption of advanced technologies. So, let’s analyze whether pharmaceutical stocks Kamada (KMDA), Neurocrine Biosciences (NBIX), and Novartis (NVS) are well positioned to capitalize on the industry’s growth prospects.

Learn about the recent recall of ResMed's respiratory devices by the US FDA, deemed as the most serious. Find out more about the implications and what acti...

The FDA states that popular drugs for diabetes and obesity do not appear to be linked to suicidal thoughts but continues to investigate reports.

Federal officials say a preliminary review finds no connection between suicidal thoughts and a new class of diabetes and obesity drugs

People with obstructive sleep apnea symptoms can now get a diagnosis and treatment much sooner, thanks to a pioneering sleep apnea detection device.